Biontech Se ADR (BNTX) Stock Price, Quote & News

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical tri...

Industry: Biotechnology

Sector: Healthcare

Phone: 49 6131 9084

Fax: 49 6131 9084

Website: www.biontech.de

Address:

An der Goldgrube 12, Mainz, Germany

taxplanr Jan. 10 at 12:43 AM

Stage 4 breast cancer results using Ivermectin and red light therapy $BNTX $MRNA $PFE https://www.tiktok.com/t/ZThF5pvTM/

0 · Reply

taxplanr Jan. 9 at 4:21 PM

I know you $BNTX investors will be thrilled by this study out of the UAE Egypt and Saudi about how Ivermectin works to kill lung cancer cells $MRNA $PFE It's a race for the Cure https://pubmed.ncbi.nlm.nih.gov/40174264/

0 · Reply

taxplanr Jan. 9 at 3:03 PM

CDC wasn't the only one misleading $BNTX $MRNA $PFE https://justthenews.com/accountability/watchdogs/cdc-misled-public-study-implying-covid-vaccines-save-healthy-kids-ucla?utm_source=mux&utm_medium=social-media&utm_campaign=social-media-autopost

0 · Reply

taxplanr Jan. 9 at 2:56 PM

Even advanced stage concers seem to fade against the IFM combo $BNTX $MRNA $PFE https://makisw.substack.com/p/ivermectin-fenbendazole-and-mebendazole-1c8?utm_source=post-email-title&publication_id=1385328&post_id=183929305&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

taxplanr Jan. 9 at 1:29 PM

He got bladder cancer in 2022. Isn't that odd timing? $BNTX $MRNA $PFE https://trendingpoliticsnews.com/the-middle-star-passes-away-at-60-trin/?utm_source=DS21

0 · Reply

taxplanr Jan. 9 at 3:04 AM

What will $BNTX $MRNA $PFE and friends thin of next? https://anamihalceamdphd.substack.com/p/government-assurances-of-biotech?utm_source=post-email-title&publication_id=956088&post_id=183965336&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

taxplanr Jan. 8 at 5:20 PM

$PFE $BNTX has known about DNA contamination of the C19 jabs for at least 2 years https://www.instagram.com/reel/DTO5wf1iBxG/?igsh=MWhwd2Q2MjJqejBkaA==

0 · Reply

TheRealShortSqueezy Jan. 8 at 4:24 PM

🧬 $PDSB Advancing Immunotherapy in Cancer & Infectious Disease 🧪 PDS Biotechnology is a immunotherapy company developing targeted treatments for cancer and infectious diseases using its proprietary Versamune and Infectimune platforms. 👉🏽 Phase 3 lead asset: Versamune HPV for HPV16-positive head & neck cancer 👉🏽 Proven immune activation: Strong T-cell responses and durable survival 👉🏽 Focused strategy: Clear oncology lead with combination potential 👉🏽 Execution-driven: Capital aligned to complete Phase 3 development Their unique technology: 🔬 Versamune: Programs tumor-specific killer T cells 🔬 Infectimune: Applies immune programming beyond oncology Supported by leading academic and NCI-backed institutions, PDS Biotechnology is progressing a Phase 3 oncology program with significant upside potential. Communicated Disclaimer: https://stockresearchtoday.com/revolutionizing-biotech-for-cancer-treatment/ Sector Peers: $PFE $AMGN $MRK $BNTX

0 · Reply

htw7448 Jan. 7 at 8:36 PM

$BNTX will grow to the biggest oncology giant within next 6-8 years. A lot of upside potential.

0 · Reply

Pillemann1 Jan. 7 at 8:11 PM

$BNTX ??

0 · Reply

University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund

Dec 18, 2025, 4:45 AM EST - 23 days ago

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

Dec 9, 2025, 5:54 PM EST - 4 weeks ago

BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart

Dec 9, 2025, 7:00 AM EST - 4 weeks ago

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

BMY

Dec 6, 2025, 3:30 PM EST - 5 weeks ago

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Dec 3, 2025, 9:01 AM EST - 5 weeks ago

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

CVAC

Dec 1, 2025, 3:50 PM EST - 5 weeks ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

MRNA NVAX PFE

Dec 1, 2025, 12:35 PM EST - 5 weeks ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

MRNA NVAX PFE

Nov 26, 2025, 7:30 AM EST - 6 weeks ago

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Nov 17, 2025, 6:17 PM EST - 7 weeks ago

BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript

Nov 13, 2025, 5:20 PM EST - 2 months ago

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

PFE

Nov 13, 2025, 11:10 AM EST - 2 months ago

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

PFE

Nov 13, 2025, 8:17 AM EST - 2 months ago

BioNTech says collaboration with Pfizer remains unchanged

PFE

Nov 3, 2025, 1:44 PM EST - 2 months ago

BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold

Nov 3, 2025, 12:46 PM EST - 2 months ago

BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 10:29 AM EST - 2 months ago

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership

BMY

Nov 3, 2025, 6:47 AM EST - 2 months ago

BioNTech lifts 2025 revenue guidance on BMS partnership payment

Nov 3, 2025, 6:45 AM EST - 2 months ago

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

Oct 28, 2025, 7:45 AM EDT - 2 months ago

BioNTech to Host Innovation Series R&D Day on November 11, 2025

Oct 27, 2025, 7:45 AM EDT - 2 months ago

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

Oct 22, 2025, 6:45 AM EDT - 2 months ago

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Oct 18, 2025, 9:30 AM EDT - 3 months ago

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

MRNA

Oct 1, 2025, 6:52 PM EDT - 3 months ago

BioNTech SE, InstaDeep Ltd - Special Call

Sep 23, 2025, 6:45 AM EDT - 3 months ago

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Sep 19, 2025, 11:40 AM EDT - 4 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

MRNA NVAX PFE

Sep 12, 2025, 1:37 PM EDT - 4 months ago

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

JNJ KVUE MRNA PFE

Sep 8, 2025, 2:01 PM EDT - 4 months ago

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BMY

Sep 8, 2025, 11:05 AM EDT - 4 months ago

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

BMY

Sep 8, 2025, 11:00 AM EDT - 4 months ago

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Sep 8, 2025, 7:02 AM EDT - 4 months ago

Pfizer, partner BioNTech say updated COVID shot shows better immune response

PFE

Sep 8, 2025, 6:45 AM EDT - 4 months ago

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

PFE

Sep 5, 2025, 5:13 AM EDT - 4 months ago

BioNTech, Duality score initial trial win with breast cancer precision drug

Aug 28, 2025, 6:20 AM EDT - 4 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY DHR GRAL ILMN IONS MRNA RGEN

Aug 27, 2025, 12:50 PM EDT - 4 months ago

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

PFE

Aug 7, 2025, 9:00 PM EDT - 5 months ago

CureVac settles patent dispute litigation with Pfizer and BioNTech

CVAC PFE

Aug 5, 2025, 1:36 PM EDT - 5 months ago

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

Aug 4, 2025, 1:56 PM EDT - 5 months ago

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 10:32 AM EDT - 5 months ago

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

Aug 4, 2025, 7:01 AM EDT - 5 months ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

Aug 4, 2025, 6:52 AM EDT - 5 months ago

BioNTech's Q2 revenues double on higher COVID vaccine sales

Aug 4, 2025, 6:45 AM EDT - 5 months ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Aug 1, 2025, 4:51 PM EDT - 5 months ago

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

MRNA PFE

Aug 1, 2025, 8:31 AM EDT - 5 months ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

Aug 1, 2025, 6:54 AM EDT - 5 months ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Aug 1, 2025, 5:59 AM EDT - 5 months ago

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

MRNA PFE

Jul 31, 2025, 7:00 AM EDT - 5 months ago

Pandemic darlings Moderna, BioNTech are now on two different paths

MRNA

Jul 25, 2025, 2:30 AM EDT - 6 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 6 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

PFE

Jul 23, 2025, 4:11 AM EDT - 6 months ago

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

PFE

Jul 21, 2025, 6:45 AM EDT - 6 months ago

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

taxplanr Jan. 10 at 12:43 AM

Stage 4 breast cancer results using Ivermectin and red light therapy $BNTX $MRNA $PFE https://www.tiktok.com/t/ZThF5pvTM/

0 · Reply

taxplanr Jan. 9 at 4:21 PM

0 · Reply

taxplanr Jan. 9 at 3:03 PM

0 · Reply

taxplanr Jan. 9 at 2:56 PM

0 · Reply

taxplanr Jan. 9 at 1:29 PM

He got bladder cancer in 2022. Isn't that odd timing? $BNTX $MRNA $PFE https://trendingpoliticsnews.com/the-middle-star-passes-away-at-60-trin/?utm_source=DS21

0 · Reply

taxplanr Jan. 9 at 3:04 AM

0 · Reply

taxplanr Jan. 8 at 5:20 PM

$PFE $BNTX has known about DNA contamination of the C19 jabs for at least 2 years https://www.instagram.com/reel/DTO5wf1iBxG/?igsh=MWhwd2Q2MjJqejBkaA==

0 · Reply

TheRealShortSqueezy Jan. 8 at 4:24 PM

0 · Reply

htw7448 Jan. 7 at 8:36 PM

$BNTX will grow to the biggest oncology giant within next 6-8 years. A lot of upside potential.

0 · Reply

Pillemann1 Jan. 7 at 8:11 PM

$BNTX ??

0 · Reply

taxplanr Jan. 7 at 3:36 PM

Did you all see this China study on Fenbendazole on Anti-Tumor effects against cervical cancer? $BNTX $MRNA $PFE https://pubmed.ncbi.nlm.nih.gov/40509264/

0 · Reply

taxplanr Jan. 7 at 3:28 PM

Ivermectin Fenbendazole and CLO2 killing cancer $BNTX $MRNA $PFE https://makisw.substack.com/p/ivermectin-fenbendazole-and-chlorine?utm_source=post-email-title&publication_id=1385328&post_id=183774487&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

tkstockpicker Jan. 7 at 3:26 PM

$BNTX added

0 · Reply

taxplanr Jan. 7 at 2:47 PM

$BAYRY suing malignantRNA makers $BNTX $MRNA $PFE over misusing it's mRNA patent Gates companies lawfaring against Gates companies 🤣 https://www.reuters.com/legal/litigation/bayer-sues-covid-vaccine-makers-over-mrna-technology-2026-01-06/

0 · Reply

OpenOutcrier Jan. 7 at 1:41 PM

$PFE $BNTX $MRNA Bayer sues COVID vaccine makers over mRNA technology - Reuters https://ooc.bz/l/88868

1 · Reply

htw7448 Jan. 6 at 4:07 PM

$BNTX : are there any links for data readout available?

0 · Reply

taxplanr Jan. 6 at 2:57 PM

$BNTX $MRNA $PFE the whole world is learing 🤣 how to cure cancer https://makisw.substack.com/p/mebendazole-in-ovarian-cancer-how?utm_source=post-email-title&publication_id=1385328&post_id=183659427&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

2 · Reply

StockAnalyst_SA Jan. 6 at 2:51 PM

🟢 $ZETA | DA Davidson Buy PT $29 Full analysis here! It's free👉 @StockAnalyst_SA (No noise !!) 📈 Stock Move After-hours +8% (up ~9% intraday) Driven by strategic collaboration with OpenAI 🤖 Partnership Highlights Integrating OpenAI models + ZETA Athena Two new agentic apps: Insights & Advisor Athena GA by end of 1Q26 (was 1H26) 💡 Takeaway Reiterate BUY / PT $29 Valuation: 30x 2026 FCF Tech + strategic collaboration → long-term growth potential $BNTX $LH $PPG $CG

0 · Reply

taxplanr Jan. 6 at 2:50 PM

$BNTX $MRNA $PFE the new Cancer Cure narrative is underway Just add Cannabis oil https://makisw.substack.com/p/ivermectin-mebendazole-and-fenbendazole-180?utm_source=post-email-title&publication_id=1385328&post_id=182971446&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

taxplanr Jan. 6 at 2:45 PM

$BNTX $MRNA $PFE the insider dump is coming again

0 · Reply

taxplanr Jan. 6 at 1:25 PM

Sector rotation is under way $PFE $BNTX $MRNA $MRK Today, the Trump Administration is proud to announce the United States of America’s updated Childhood Vaccination Schedule. This Schedule is rooted in the Gold Standard of Science, and widely agreed upon by Scientists and Experts all over the World. Effective today, America will no longer require 72 “jabs” for our beautiful, healthy children. We are moving to a far more reasonable Schedule, where all children will only be recommended to receive Vaccinations for 11 of the most serious and dangerous diseases. Parents can still choose to give their children all of the Vaccinations, if they wish, and they will still be covered by insurance. However, this updated Schedule finally aligns the United States with other Developed Nations around the World. Congratulations to HHS Secretary Bobby Kennedy, CDC Acting Director ... https://truthsocial.com/@realDonaldTrump/115844861259246664

1 · Reply

taxplanr Jan. 5 at 8:55 PM

$BNTX insider dump coming

0 · Reply

Market Cap	22.48B
Revenue (ttm)	2.98B
Net Income (ttm)	-719.92M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-24.18%
Debt to Equity Ratio	0.01

Volume	728,900
Avg Vol	1,151,146
Day's Range	N/A - N/A
Shares Out	225.18M
Stochastic %K	78%
Beta	1.40
Analysts	Strong Sell
Price Target	$139.85